European Organisation for Research and Treatment of Cancer

📅 Save the date! EORTC events are back in 2026 ⬇️ #CancerResearch #ClinicalTrials #Oncology #EORTCevents

#ESMO26 concluded yesterday after five days of scientific exchange across the oncology community. Catch up on the key EORTC studies, presentations and highlights from this year's congress ⬇️ 🔗 www.eortc.org/blog/2026/10... #EORTC #CancerResearch @myesmo.bsky.social

Presented at #ESMO26: final results from the PEARLS/KEYNOTE-091 study. Dr Mary O’Brien shared long-term follow-up data on adjuvant pembrolizumab in patients with completely resected stage IB-IIIA NSCLC. Read the key takeaways from the presentation below ⬇️ #EORTC #NSCLC @myesmo.bsky.social

📌 #ESMO26 e-poster spotlight “Are we measuring the symptoms that matter most to patients? Our analysis shows existing @eortc.org questionnaires capture most common treatment-related symptoms in #HeadNeckCancer.” Congrats to @mkmoutafi.bsky.social et al. 👏 #GivingVoice2Patients @myesmo.bsky.social

📌 #ESMO26 Poster How comparable are PFS results across cancer trials? A systematic review of 156 oncology studies found considerable variation in how intercurrent events were handled and reported, highlighting the need for greater standardisation & transparency. #CancerResearch @myesmo.bsky.social

Come and meet us at #ESMO26 at booth S1041, Hall 10 👋 Find out how to submit your research to #EORTCSummit, explore EORTC membership and discover all the opportunities to get involved in our clinical research. @myesmo.bsky.social

At today’s #ESMO2026 Policy session, Iryna Shakhnenko presented findings from an EORTC study on patient partner reviews of informed consent forms across 49 clinical trials. 👏 Congratulations to Iryna on presenting this work. See the key highlights below. 👇

📄 New in @hemasphere-journal.bsky.social Researchers from the i-BFM Study Group, including contributors from EORTC, identified favorable subgroups of pediatric high-hyperdiploid ALL in a retrospective multinational study that included data from the EORTC-CLG 58951 trial. doi.org/10.1002/hem3...

📍 We're in Madrid for #ESMO26! The EORTC team is at booth S1041 throughout the congress. If you're attending ESMO, stop by to meet the team and learn more about our research and collaborations. We'd love to see you there! 👋 #EORTC #CancerResearch @myesmo.bsky.social

📢 #ESMO26 Congress opens tomorrow in Madrid. Throughout the congress, EORTC researchers and collaborators will present multidisciplinary research across oral presentations, mini orals, posters, e-posters and trials in progress. 🔗 Explore our abstract overview: www.eortc.org/blog/2026/10...

👏 Proud to see the EORTC Quality of Life Group presenting innovative research at #ISOQOL 2026, from paediatric oncology and survivorship to patient-reported outcome (PRO) interpretation and implementation. 👇 #QualityofLife #GivingVoice2Patients #CancerResearch

🎀 #PinkOctober: Can genomic testing help avoid unnecessary chemotherapy in breast cancer? Meet Betty, a participant in the MINDACT study. Learn more: www.eortc.org/blog/2026/10... 🎥 Watch her story: #MINDACT #EORTCbreast

📖 Yesterday afternoon at #ISOQOL, @msztankay.bsky.social presented the @eortc.org Patient-Reported Outcome Interpretation Guideline. The project also introduces new resources to help patients understand EORTC PRO data, coming soon on our EORTC #QualityofLife Group website. #GivingVoice2Patients

What does it take to move from protocol to patient? Today at @eanm.org 2026, our past president, @winettevandergraaf.bsky.social, shared practical lessons from multinational academic clinical trials across Europe drawing on years of experience in international cancer research. #EANM26

💡 This afternoon at #ISOQOL, Andreia Moura shared findings on how to improve PROM completion in cancer clinical trials. Key takeaways: reduce questionnaire redundancy, support patients & ensure site staff understands the value of PRO data collection. #GivingVoice2Patients #QualityofLife @eortc.org

📊 We're hiring a Senior Statistician to support the design, analysis and reporting of international clinical trials at EORTC. Join a multidisciplinary team advancing cancer research through data-driven science. 🔗 Apply now: www.eortc.org/job/senior-s... #ClinicalTrials

📍 At #EANM26? Visit EORTC at booth 11 in the Society Village! Don't miss our Joint Symposium today at 15:00 in Hall F2 on clinical trial design for RLTs. European Association of Nuclear Medicine (EANM) #ClinicalTrials #CancerResearch #RadioligandTherapy #RLT #Oncology

📢 EORTC is at #EANM26! Among the programme highlights are a joint symposium with the EANM Oncology & Theranostics Committee on evidence generation for radioligand therapies and a presentation by Winette Van der Graaf on multinational academic trials across Europe.

50 years of supporting progress in cancer research! Relive the highlights of the EORTC Cancer Research Fund's anniversary Gala Dinner and celebrate five decades of impact. Watch the aftermovie: www.eortcresearchfund.org/anniversary/ #EORTC #ECRF #CancerResearch

🚨 Final days to submit your LBA! Last chance to share your latest research with the ENA community. Deadline: This Monday 👉 Submit now: https://event.eortc.org/ena2026/late-breaking-abstracts/ American Association for Cancer Research (AACR) & The National Cancer Institute #ENASymp26

Proud to see the EORTC Quality of Life Group presenting 16 abstracts at #ISOQOL 2026 next week, contributing to advances in patient-centred cancer research. 👇 #QualityofLife #GivingVoice2Patients #CancerResearch

We are looking forward to #ISOQOL 2026 in Prague! The @eortc.org #QualityofLife Group will present 16 abstracts (6 oral, 10 poster) showcasing advances in PRO & HRQoL research, paediatric oncology, survivorship and questionnaire development. 🔗 www.eortc.org/blog/2026/10... #GivingVoice2Patients

📢 We're hiring an EU Grant Officer. If you have experience with EU-funded projects and enjoy working in an international research environment, we'd like to hear from you. 🔗Apply here: www.eortc.org/job/eu-grant... #Hiring #EORTC #CancerResearch #EUJobs

How can Europe better support low-risk, treatment optimisation trials? Selected among the Top 3 abstracts at the ECO Summit, this new EORTC abstract compares EU, UK and Swiss frameworks for low-intervention clinical trials and calls for more proportionate regulation. 🔗 doi.org/10.1016/j.ej...

🎀 #PinkOctober: How do treatment decisions impact patients decades later? EORTC-22922/10925 trial: 20-year follow-up includes a node-negative analysis published in @thelancetoncol.bsky.social, exploring regional lymph node irradiation. 🎥 Watch now 🔗 www.eortc.org/blog/2026/10... #EORTCbreast

📢 We're hiring a Medical Liaison Officer (MLO)! Join the EORTC Medical Department and help support our scientific groups, committees and international cancer research activities. 🔗 Apply here: eortc.org/job/medical-... #WeAreHiring #CancerResearch

Europe's leadership in biotechnology depends on turning innovation into real-world patient benefit. EORTC CEO Denis Lacombe is participating in today's Expert Dialogue on the EU Biotech Act at the @europarl.europa.eu, bringing the academic cancer research perspective. #EUBiotechAct

🚨 LBA submission is OPEN! Share your latest, practice-changing research with the ENA community. Submit by 19 October! 👉 https://event.eortc.org/ena2026/late-breaking-abstracts/ American Association for Cancer Research (AACR) & The National Cancer Institute #ENASymp26 #CancerResearch #Oncology

📢 We're hiring! EORTC is looking for a Receptionist & Administrative Assistant (50% part-time). Organised, customer-focused, fluent in English and French? We'd love to hear from you. 👉 Full job description & application: www.eortc.org/job/receptio...

🎀 This #PinkOctober: meet the EORTC Breast Cancer Group, 770+ experts advancing breast cancer research. 🔬TREAT ctDNA, APPALACHES, AURORA, NEOLDER & more. Read more: www.eortc.org/blog/2026/10... #EORTCbreast #BreastCancerAwareness

💬 Putting patients at the heart of cancer research. For #ECRF50, Mila Ogalla Toledo shares her journey into patient advocacy and hopes for the future of cancer care. 👉 Read her story: https://www.eortcresearchfund.org/2026/10/01/putting-patients-at-the-heart-of-cancer-research/

A new review from the ESTRO CNS Focus Group explores the role of reirradiation in recurrent brain tumours, highlighting opportunities, challenges and future research needs. 🔗 Read the publication: doi.org/10.1016/j.ct... #NeuroOncology #ESTRO #EORTC

Access to cancer clinical trials remains uneven across Europe. In a new ESMO Open publication, authors including EORTC CEO Denis Lacombe highlight the need to close the "trial access gap" and strengthen support for meaningful academic cancer research. 🔗 www.esmoopen.com/article/S205...

📢 First patient enrolled in the melanoma cohort of the EORTC-SPECTA 2148 MRD study. The study is evaluating whether circulating tumour DNA (ctDNA) can help detect cancer recurrence earlier and improve patient follow-up after curative treatment. 🔗 spectaplatform.org/2026/10/02/f...

Save the dates for the next @eortc.org #QualityofLife Group meetings! 📅 15-16 April 2027 | Oslo, Norway 📅 30 Sep-1 Oct 2027 | Warsaw, Poland Looking forward to another year of collaboration and scientific exchange. 🔗 qol.eortc.org/events/ #GivingVoice2Patients #QLGmeeting

Over the past three days, the EU Cancer Mission showcase brought together stakeholders from across Europe to discuss the future of cancer research and care. We were pleased to see @winettevandergraaf.bsky.social contribute to discussions on rare cancers and clinical research. @ec.europa.eu

📢 A new IMMUcan publication in Cell Reports Medicine sheds light on response to chemo-immunotherapy in advanced #TNBC and highlights the contribution of the EORTC-1553-SPECTA platform to translational cancer research. Read more: spectaplatform.org/2026/09/30/i... #IMMUcan #SPECTA

📢 Call for Abstracts is OPEN for #EORTCSummit 2027! Submit your research and share it with the clinical cancer research community. 📅 Abstract submission: 30 September – 4 November 2026 👉 https://event.eortc.org/summit/abstracts/ #CancerResearch #ClinicalResearch #Oncology

💬 Beyond survival New CSO–EORTC recommendations highlight the importance of reporting not only treatment benefits, but also how many patients experience a meaningful deterioration in quality of life & for how long. 🔗 www.eortc.org/blog/2026/09... @csoncol.bsky.social @qol.eortc.org #QualityofLife

From ROAM/EORTC 1308 to VIGOR and new glioma research, EORTC abstracts contributed important evidence presented at #EANO2026. 🔗 Read more: https://www.eortc.org/blog/2026/09/28/eortc-presents-new-results-at-eano/ EANO #EORTCbrain

👏Raffaella presenting at #EANO2026 today. The ARGOS post hoc analysis of EORTC-1709-BTG/CCTG CE.8 (MIRAGE) explored the relationship between radiotherapy quality assurance (RTQA), uninvolved-brain dose, survival, and treatment-related toxicity in patients with glioblastoma.

On 22 September, ECRF celebrated 50 years of supporting cancer research at a Gala Dinner in Brussels, with HRH Princess Dina Mired, representatives of the Belgian Royal House, and Ambassadors of Jordan, Belgium and Monaco. Thank you to all our supporters! #EORTC #ECRF50

👏 International academic collaboration delivering answers. Just presented at #EANO2026, the ROAM/EORTC-1308 phase III trial found that radiotherapy significantly reduces recurrence risk after complete resection of atypical meningioma. 🔗 www.eortc.org/blog/2026/09... @eanoassociation.bsky.social

#EANO2026 Chair Giuseppe Minniti takes the stage to officially open the congress, kicking off a packed programme with 44 scientific sessions, poster presentations, and contributions from scientific partners such as @eortc.org #radiotherapy #EANO #EORTC

🚀 The EORTC 2335-GUCG #BRACE study has reached an important milestone with the inclusion of its first patient. 👏 Congratulations to all study coordinators, investigators and research teams involved, as well as to the first patient participating in the study. 🔗 www.eortc.org/blog/2026/08...

📢 Get ready for #ENASymp26 Late-Breaking Abstract submissions! Submit your latest data 12–19 October 2026. 📍 Barcelona 18–20 November 👉 Register: https://event.eortc.org/ena2026/registration/ American Association for Cancer Research (AACR) The National Cancer Institute #CancerResearch #Oncology

At today’s #WorldCancerResearchDay event, Denis Lacombe, CEO of EORTC: "World Cancer Research Day reminds us that better cancer care is not always about more treatment, but about the right treatment for the right patient, supported by strong academic cancer research."

📢 Join us live at 15:00 CEST! Today, cancer research leaders gather in Brussels to mark the 10th Anniversary of #WorldCancerResearchDay. We are honoured to welcome Her Majesty Queen Letizia of Spain and HRH Princess Dina Mired of Jordan. 🎥Follow live on YouTube: www.youtube.com/live/35YcRy-...